High-Intensity Interval Training in Low Versus Normal Oxygen: Effects on Body Fat and Gut Health in Adults Aged 50-75 With Overweight or Obesity (HYPOXFAT) (HYPOXFAT)
High-intensity Interval Training Under Hypoxic Versus Normoxic Conditions: Effects on Fat Mass Loss and Gut Microbiota in Adults Aged 50-75 With Overweight or Obesity
Overweight and obesity are major public health challenges worldwide, and their prevalence increases with age, partly because of age-related metabolic and hormonal changes. Beyond total fat mass, abdominal and particularly visceral fat accumulation is strongly associated with chronic low-grade inflammation, insulin resistance, hypertension and cardiovascular disease. Men are more likely to display an android fat distribution, while premenopausal women generally show a more protective gynoid distribution. However, declining sex hormone concentrations after menopause promote abdominal and visceral fat accumulation, increasing cardiometabolic risk.
Physical activity is a cornerstone of overweight and obesity management. High-intensity interval training (HIIT) is an effective strategy for reducing total, abdominal and visceral fat and may produce greater benefits than moderate-intensity continuous training. Since 2016, our team has conducted several studies and reviews showing that HIIT performed on a cycle ergometer or treadmill, alone or combined with resistance training, reduces total and abdominal fat mass in people with overweight or obesity, regardless of age, sex or hormonal status.
HIIT can also be performed under real or simulated hypoxic conditions to enhance cardiovascular, respiratory, circulatory, haematological and skeletal muscle adaptations. The Live Low-Train High model allows participants to live under normoxic conditions while being exposed to hypoxia only during exercise. Hypoxic HIIT has proved feasible and safe in people with metabolic disorders or physical deconditioning, including at simulated altitudes of 4,000-5,000 m. However, only two studies have suggested that hypoxic HIIT may enhance fat mass loss in people with overweight or obesity. Neither specifically assessed abdominal or visceral fat, and neither focused on postmenopausal women.
Several mechanisms may contribute to HIIT-induced fat loss, including increased catecholaminergic stimulation and lipid oxidation during recovery, excess post-exercise oxygen consumption and changes in appetite regulation. The gut microbiota may also contribute to the regulation of adipose tissue and cardiometabolic health. Physical activity can increase bacterial diversity and promote beneficial taxa, particularly short-chain fatty acid-producing bacteria. Our previous HIIT studies identified associations between changes in selected bacteria and reductions in total or abdominal fat mass. Hypoxic exposure may also alter gut microbiota composition and abundance, with effects depending on the severity and type of hypoxia.
This study will assess the effects of a 3-month cycle-ergometer HIIT programme, performed three times per week under hypoxic versus normoxic conditions, in adults aged 50-75 years with overweight or obesity. The primary objective is to determine whether hypoxic HIIT produces a greater reduction in abdominal and visceral fat mass than the same training performed in normoxia.
Secondary outcomes will include total and regional fat and lean mass; fasting glucose, insulin, HbA1c and HOMA-IR; total cholesterol, triglycerides, HDL-C, LDL-C, ApoB, ApoA1 and the ApoB/ApoA1 ratio; high-sensitivity C-reactive protein and fibrinogen; systolic and diastolic blood pressure; blood biophysical properties; and faecal microbiota richness, diversity and taxonomic composition. Lipid oxidation during prolonged moderate-intensity exercise, maximal oxygen uptake and maximal aerobic power will also be assessed before and after the intervention.
We hypothesise that hypoxic training will enhance improvements in body composition, metabolic and cardiovascular risk factors, aerobic fitness and lipid oxidation compared with normoxic training. We further hypothesise that hypoxia will modify faecal microbiota composition and that changes in selected bacterial taxa will be associated with changes in body composition and cardiovascular risk markers.
The ultimate aim is to improve the management of adults aged 50-75 years with overweight or obesity by developing an effective 3-month HIIT programme performed under controlled hypoxic conditions.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Nathalie BOISSEAU, Professor
- 전화번호: +33684331693
- 이메일: nathalie.boisseau@uca.fr
연구 장소
-
-
-
Bellerive-sur-Allier, 프랑스, 03321
- 모병
- CREPS Auvergne Rhône-Alpes / Vichy
-
연락하다:
- Nathalie BOISSEAU, Pr
- 전화번호: +33 0473405519
- 이메일: nathalie.boisseau@uca.fr
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
Aged 50-75 years, inclusive Male or postmenopausal female, defined as no menstruation during the previous 12 months Body mass index between 25 and 35 kg/m², inclusive Non-smoker or smoking no more than two cigarettes per day Stable body weight for at least three months before study initiation, defined as a change of less than 4 kg Stable dietary habits and physical activity level for at least three months before study initiation Willing to maintain usual dietary habits and physical activity level throughout the study Able and willing to comply with the study protocol Able and willing to provide written informed consent Affiliated with a social security scheme Willing to be registered in the French National Register of Volunteers Participating in Biomedical Research
Exclusion Criteria:
Medical or surgical history considered by the investigators to be incompatible with participation in the study Any medical condition considered by the investigators to be incompatible with participation in the study Medical contraindication to vigorous physical activity Current use of hormone replacement therapy Current use of beta-blocker therapy Diagnosed moderate-to-severe sleep apnoea syndrome that is untreated or inadequately controlled High-risk cardiovascular history, including symptomatic coronary artery disease, recent myocardial infarction or stroke, unstable heart failure, clinically significant arrhythmia, or uncontrolled hypertension Severe respiratory disease, including advanced chronic obstructive pulmonary disease classified as group B or E according to the 2023 GOLD classification, chronic respiratory failure, or uncontrolled asthma Diabetes of any type Chronic kidney disease stage 3B, 4 or 5 according to the KDIGO classification Severe liver disease, defined by an international normalised ratio greater than 1.2-1.3 Antibiotic treatment during the three months preceding the first stool collection More than eight hours of moderate-to-vigorous physical activity per week Any treatment that, in the investigators' opinion, could interfere with assessment of the study outcomes Low-energy diet during the three months preceding the study or intention to begin an energy-restricted diet during the study Extreme dietary habits Stay at an altitude above 2,500 m for more than eight days during the three months preceding the study Participation in another clinical study or currently within an exclusion period following participation in a previous clinical study Total compensation received for participation in research since the beginning of the calendar year exceeding €4,500, or the applicable regulatory limit Linguistic or psychological inability to provide informed consent Refusal to provide written informed consent Legally protected adult Deprived of liberty by an administrative or judicial decision Under guardianship or curatorship
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Hypoxic HIIT (HIIT-H)
Participants will complete a 12-week cycle-ergometer HIIT programme, with three sessions per week, under normobaric hypoxia (FiO₂: 15%; simulated altitude: 3,000 m).
|
Participants will complete 36 cycle-ergometer HIIT sessions over 12 weeks (three sessions per week) under normobaric hypoxia (FiO₂: 15%; simulated altitude: 3,000 m).
Each session will include a 5-minute warm-up followed by 60 repetitions of 8 seconds of acceleration at approximately 80-85 rpm and 12 seconds of deceleration at approximately 60 rpm.
The 8-second efforts will be performed at 75-80% of maximal aerobic power.
다른 이름들:
|
|
활성 비교기: Normoxic HIIT (HIIT-N)
Participants will complete the same 12-week cycle-ergometer HIIT programme, with three sessions per week, under normoxic conditions (FiO₂: 21%).
|
Participants will complete 36 cycle-ergometer HIIT sessions over 12 weeks (three sessions per week) under normoxic conditions (FiO₂: 21%).
Each session will include a 5-minute warm-up followed by 60 repetitions of 8 seconds of acceleration at approximately 80-85 rpm and 12 seconds of deceleration at approximately 60 rpm.
The 8-second efforts will be performed at 75-80% of maximal aerobic power.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Relative Change in Total Abdominal Fat Mass
기간: Baseline and immediately after the 12-week intervention
|
Total abdominal fat mass will be measured by dual-energy X-ray absorptiometry (DXA) at baseline and after the 12-week intervention.
The relative change will be calculated as: (abdominal fat mass at 12 weeks - abdominal fat mass at baseline) / abdominal fat mass at baseline.
More negative values indicate a greater reduction in abdominal fat mass.
The change will be compared between the hypoxic and normoxic HIIT groups.
|
Baseline and immediately after the 12-week intervention
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Relative Change in Body Mass
기간: Baseline and after 12 weeks of intervention
|
Description: Body mass will be measured in kilograms at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between the hypoxic and normoxic HIIT groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Visceral Abdominal Fat Mass
기간: Baseline and after 12 weeks of intervention
|
Description: Visceral abdominal fat mass will be measured by DXA at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Total Lean Mass
기간: Baseline and after 12 weeks of intervention
|
Description: Total lean mass will be measured in kilograms by DXA at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Waist-to-Hip Ratio
기간: Baseline and after 12 weeks of intervention
|
Description: The waist-to-hip ratio will be calculated by dividing waist circumference by hip circumference at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in metabolic Plasma parameters (TG, HBA1C, glucose, insulin, HDL, LDL)
기간: Baseline and after 12 weeks of intervention
|
Fasting concentration will be measured at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Whole Blood Viscosity
기간: Baseline and after 12 weeks of intervention
|
Whole blood viscosity will be assessed using standardised haemorheological procedures at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Red Blood Cell Deformability
기간: Baseline and after 12 weeks of intervention
|
Description: Red blood cell deformability will be assessed using standardised haemorheological procedures at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Red Blood Cell Aggregation
기간: Baseline and after 12 weeks of intervention
|
Description: Red blood cell aggregation will be assessed using standardised haemorheological procedures at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Change in the Relative Abundance of Prespecified Gut Bacterial Taxa
기간: Baseline and after 12 weeks of intervention
|
Description: The relative abundance of prespecified bacterial taxa will be determined from faecal microbiota samples collected at baseline and after the 12-week intervention.
Changes in relative abundance will be compared between the hypoxic and normoxic HIIT groups.
|
Baseline and after 12 weeks of intervention
|
|
Change in Faecal Gut Microbiota Alpha Diversity
기간: Baseline and after 12 weeks of intervention
|
Description: Alpha-diversity indices reflecting within-sample bacterial richness and diversity will be calculated from faecal microbiota samples collected at baseline and after the 12-week intervention.
Changes will be compared between the hypoxic and normoxic HIIT groups.
|
Baseline and after 12 weeks of intervention
|
|
Change in Faecal Gut Microbiota Beta Diversity
기간: Baseline and after 12 weeks of intervention
|
Description: Beta diversity, reflecting differences in bacterial community composition, will be assessed using faecal samples collected at baseline and after the 12-week intervention.
Changes in community composition will be compared between the hypoxic and normoxic HIIT groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Maximal Aerobic Power
기간: Baseline and after 12 weeks of intervention
|
Description: Maximal aerobic power, expressed in watts, will be determined during a maximal exercise test at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Lipid Oxidation Rate During Submaximal Exercise
기간: Baseline and after 12 weeks of intervention
|
Description: Lipid oxidation rate, expressed in grams per minute, will be calculated by indirect calorimetry during 45 minutes of fasted exercise performed at 50% of V̇O₂max, at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
|
Relative Change in Carbohydrate Oxidation Rate During Submaximal Exercise
기간: Baseline and after 12 weeks of intervention
|
Description: Carbohydrate oxidation rate, expressed in grams per minute, will be calculated by indirect calorimetry during 45 minutes of fasted exercise performed at 50% of V̇O₂max, at baseline and after the 12-week intervention.
Relative change will be calculated as: (week 12 value - baseline value) / baseline value and compared between groups.
|
Baseline and after 12 weeks of intervention
|
공동 작업자 및 조사자
스폰서
스폰서
협력자
협력자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- ID-RCB : 2025-A01744-45
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .